Venclexta (venetoclax) is a prescription drug that’s used to treat certain blood cancers. Venclexta comes as an oral tablet. Venclexta is used in adults to treat the following cancers in certain ...

Learn about Venclexta’s common, mild, and serious side effects and how to manage them. Venclexta (venetoclax) is a prescription drug used to treat acute myeloid leukemia (AML) and other cancers.

NORTH CHICAGO, Ill., Oct. 16, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA® (venetoclax) in ...

Venclexta is a targeted therapy for cancer. Here’s how it treats chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

Venclexta (venetoclax) is a brand-name oral tablet prescribed for certain types of cancer in adults. As with other drugs, Venclexta can cause side effects, such as nausea, fatigue, or dizziness.

This is not the first clinical setback for Venclexta. In 2023, AbbVie reported that a late-stage study evaluating Venclexta plus dexamethasone in certain multiple myeloma patients also failed to ...

Venclexta (venetoclax) is a brand-name oral tablet that’s prescribed for certain types of blood cancers. The cost of the drug, with and without insurance, can depend on several factors, such as ...

NORTH CHICAGO, Ill., Dec. 7, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new data from the Phase 2 CAPTIVATE (PCYC-1142) clinical ...

Safety data were consistent with the known safety profiles of IMBRUVICA and VENCLEXTA/VENCLYXTO used as individual therapies. NORTH CHICAGO, Ill., Dec. 7, 2019 /PRNewswire/ -- AbbVie ...